ZZ

Zixin Zhang

Product Owner at OnDosis

Zixin Zhang is an experienced professional currently serving as a Product Owner at OnDosis since June 2022 and as a Consultant at ADDQ since October 2018. Previously, Zixin held the position of Product Owner for TENA SmartCare at Essity, where responsibilities included defining product roadmaps and managing product backlogs. Prior experience includes roles at Volvo Group Connected Solutions as an IT Business Analyst and as a Function Owner for Volvo On Call at Volvo Car Sverige, as well as positions at Sigma Technology AB and Volvo Car Group, where leadership and coordination of feature teams were key functions. Zixin has a strong background in research and development from Huawei Technologies, focusing on 5G wireless systems and Massive MIMO systems. Educational qualifications include a Master of Science in Communication Engineering from Chalmers University of Technology and a Bachelor's degree in Electronic Information of Science & Technology from Xi’an University of Science & Technology.

Location

Gothenburg, Sweden

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


OnDosis

1 followers

OnDosis proprietary technology delivers flexible and individualized dosing of oral medicines formulated as micro units. They are focused on providing reassurance in disease management, supporting adherence and providing greater convenience for patients. OnDosis is currently developing products for individualized dosing in diseases with asignificant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes.The flexibility of OnDosis technology provides the potential for application across several disease areas and patient segments where conventional tablets or capsules often does not provide a good fit for the patient or treatment goal.OnDosis was founded in 2017 and is headquartered in Gothenburg, Sweden, based on an idea that was spun-out from AstraZeneca, using technology based on development work initiated there. It was founded by GU Ventures and Martin Olovsson. OnDosis operates a network of strategic partners across all core functions including formulation and device development, IP, Regulatory and Business Development.


Industries

Headquarters

Mölndal, Sweden

Employees

11-50

Links